  Emerging artificial enzymes with reprogrammed and augmented catalytic
activity and substrate selectivity have long been pursued with sustained
efforts. The majority of current candidates rely on noble metals or transition
metal oxides with rather poor catalytic activity compared with natural
molecules. To tackle this limitation, we strategically designed a novel
artificial enzyme based on a structurally well-defined Au25 cluster, namely
clusterzyme, which is endowed with intrinsic high catalytic activity and
selectivity driven by single-atom substitutions with modulated bond lengths.
The 3-mercaptopropionic acid (MPA)-stabilized Au24Cu1 and Au24Cd1 clusterzymes
exhibit 137 and 160 times higher antioxidant capacities than the natural
trolox, respectively. Meanwhile, the clusterzymes each demonstrate preferential
enzyme-mimicking catalytic activities with compelling selectivity: Au25
exhibits superior glutathione peroxidase-like (GPx-like) activity; Au24Cu1
shows a distinct advantage towards catalase-like (CAT-like) activity by its Cu
single active site; Au24Cd1 preferably acts as a superoxide dismutase-like
(SOD-like) enzyme via the Cd single active site. This unique diversified
catalytic landscape manifests distinctive reactions against inflammation in
brain. Au24Cu1 behaves as an endogenous multi-enzyme mimic that directly
decreases peroxide in injured brain via catalytic reactions, while Au24Cd1,
catalyzes superoxide and nitrogenous signal molecules by preference, and
significantly decreases inflammation factors such as IL-1\b{eta}, IL-6, and
TNF{\alpha}, indicative of an important role in mitigating neuroinflammation.
